View Older Stories View More Recent Stories

May 24, 2023 07:00AM Jnana Therapeutics Announces Milestone Achieved Under First Collaboration with Roche
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023 01:10AM Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 19, 2023 06:00AM Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells without Preconditioning in Non-Human Primates with Intact Immune Systems
May 18, 2023 06:00AM Be Biopharma Announces Oral Presentation on Precise Genome Engineering of Human B Cells to Express Diverse Therapeutic Proteins at American Society of Gene & Cell Therapy 26th Annual Meeting
May 16, 2023 07:00AM Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncoge
May 15, 2023 05:02PM Form SC 13G/A ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A DA32 Life Science Tech Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 04:18PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 11, 2023 09:00AM Adela Announces Appointment of Alan Williams as Chief Operating Officer
May 8, 2023 08:00AM MBX Biosciences to Participate in May Investor Conferences
May 3, 2023 08:00AM Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
May 2, 2023 05:35PM Scribe Therapeutics Announces Oral Presentation at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 2, 2023 04:30PM Be Biopharma Announces First Scientific Disclosures and New Preclinical Data Supporting the Advancement of B Cell Medicines at the American Society of Gene & Cell Therapy 26th Annual Meeting
Apr 18, 2023 04:30PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 18, 2023 12:05PM Cortica Closes $75 Million in New Funding Round and Acquires Springtide Child Development
Apr 18, 2023 08:30AM Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Apr 16, 2023 01:30PM Adela presents data demonstrating strong detection of 12 cancer types at the American Association for Cancer Research Annual Meeting 2023
Apr 13, 2023 03:30AM Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:00AM Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1
Apr 13, 2023 01:00AM Novo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics
Apr 10, 2023 05:05PM Form SC 13G NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:02PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:01PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 08:00AM MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
Apr 4, 2023 03:30AM Over DKK 3 billion (USD 413 million) raised by BioInnovation Institute portfolio companies to date
Apr 4, 2023 03:00AM Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline
Mar 31, 2023 10:00AM Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
Mar 30, 2023 05:09PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories